Wenyuan Gao

Wenyuan Gao (Tianjin Wenyuan Biotechnology) is a biotechnology company focused on the modernization and commercialization of Traditional Chinese Medicine (TCM) and natural products. Founded by Professor Wenyuan Gao of Tianjin University, the company specializes in the development of standardized botanical extracts and purified small molecules derived from medicinal plants such as Panax ginseng and Rhizoma Paridis. The company utilizes advanced pharmaceutical engineering and plant biotechnology to identify and optimize therapeutic candidates for oncology, inflammatory diseases, and metabolic disorders. Its research pipeline includes various ginsenosides and saponins that are being evaluated for their anti-tumor and anti-inflammatory properties. Wenyuan Gao serves as a key bridge between academic pharmacognosy research and the industrial production of high-quality herbal therapeutics. The entity is recognized for its contributions to the standardization and quality control of herbal medicines in China.